Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Aug;65(8):1091-5.
doi: 10.1001/archneur.65.8.1091.

Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study

Sid E O'Bryant  1 , Stephen C Waring, C Munro Cullum, James Hall, Laura Lacritz, Paul J Massman, Philip J Lupo, Joan S Reisch, Rachelle Doody; Texas Alzheimer's Research Consortium
Collaborators, Affiliations
Comparative Study

Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study

Sid E O'Bryant et al. Arch Neurol. 2008 Aug.

Abstract

Background: The Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) score is commonly used, although the utility regarding this score in staging dementia severity is not well established.

Objective: To investigate the effectiveness of CDR-SOB scores in staging dementia severity compared with the global CDR score.

Design: Retrospective study.

Setting: Texas Alzheimer's Research Consortium minimum data set cohort.

Participants: A total of 1577 participants (110 controls, 202 patients with mild cognitive impairment, and 1265 patients with probable Alzheimer disease) were available for analysis.

Main outcome measures: Receiver operating characteristic curves were generated from a derivation sample to determine optimal cutoff scores and ranges, which were then applied to the validation sample.

Results: Optimal ranges of CDR-SOB scores corresponding to the global CDR scores were 0.5 to 4.0 for a global score of 0.5, 4.5 to 9.0 for a global score of 1.0, 9.5 to 15.5 for a global score of 2.0, and 16.0 to 18.0 for a global score of 3.0. When applied to the validation sample, kappa scores ranged from 0.86 to 0.94 (P < .001 for all), with 93.0% of the participants falling within the new staging categories.

Conclusions: The CDR-SOB score compares well with the global CDR score for dementia staging. Owing to the increased range of values, the CDR-SOB score offers several advantages over the global score, including increased utility in tracking changes within and between stages of dementia severity. Interpretive guidelines for CDR-SOB scores are provided.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Receiver operating characteristic curves for Clinical Dementia Rating (CDR) Sum of Boxes scores mapping onto global CDR scores of 0 and 0.5 (area under the receiver operating characteristic curve [AUC]=0.99) (A), 0.5 and 1.0 (AUC=0.97) (B), 1.0 and 2.0 (AUC>0.99) (C), and 2.0 and 3.0 (AUC=0.97) (D).
Figure 2
Figure 2
Receiver operating characteristic curve for Clinical Dementia Rating (CDR) Sum of Boxes scores for identifying patients with Alzheimer disease and mild cognitive impairment and a global CDR score of 0.5 (area under the receiver operating characteristic curve = 0.85).
See this image and copyright information in PMC

References

    1. Horowitz F. Developmental theory, prediction, and the developmental equation in follow-up research. In: Friedman S, Haywood HC, editors. Developmental Follow-up: Concepts, Domains, and Methods. Academic Press; San Diego. CA: 1994. pp. 27–44.
    1. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A. Mapping scores onto stages: Mini-Mental State Examination and Clinical Dementia Rating. Am J Geriar Psychiatry. 2006;14(2):139–144. - PubMed
    1. Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1154–1166. - PubMed
    1. Leber P. Guidelines for the Clinical Evaluahon of Antidementia Drugs. US Food and Drug Administration; Rockville. MD: 1990.
    1. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–572. - PubMed

Publication types

MeSH terms